Results 261 to 270 of about 124,493 (360)

Toll‐Like Receptors in the Immunotherapy Era: Dual‐Edged Swords of Tumor Immunity and Clinical Translation

open access: yesMedComm, Volume 6, Issue 8, August 2025.
This review discussed the signaling pathways of Toll‐like receptors in tumors and their antitumor or protumor regulatory effects in diverse tumors. We also paid attention to the application of Toll‐like receptors in clinical treatment and summarized the clinical trial situation in recent years.
Nueraili Maihemuti   +7 more
wiley   +1 more source

SMCHD1 maintains heterochromatin, genome compartments and epigenome landscape in human myoblasts. [PDF]

open access: yesNat Commun
Huang Z   +6 more
europepmc   +1 more source

Unravelling heterochromatin [PDF]

open access: yesNature Reviews Molecular Cell Biology, 2005
openaire   +1 more source

RNA Epigenetics in Cancer: Current Knowledge and Therapeutic Implications

open access: yesMedComm, Volume 6, Issue 8, August 2025.
RNA epigenetics regulates cancer through RNA modifications, splicing, transport, and translation. Key components include m⁶A writers, splicing factors, RBPs, and nuclear export machinery. Aberrant RNA metabolism drives tumor progression and immune evasion.
Shanhe Huang   +4 more
wiley   +1 more source

Significance of stereologically spatiotemporal cells in molecular medicine

open access: yes
Clinical and Translational Discovery, Volume 5, Issue 4, August 2025.
Xuanqi Liu   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy